arrow
M

Milensu Shanyinde

university of oxford
H指数:21
被引数:3,492

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimising Prescription of Treatment In older patients with Mild hypertension at Increased risk of Serious adverse Events (OPTIMISE2): protocol for a primary care based, open-label, randomised controlled non-inferiority trial

优化高风险严重不良事件老年轻度高血压患者治疗方案(OPTIMISE2):一项基于初级保健的开放标签、随机对照非劣效性试验方案

2026-02-140
PRE
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
2024-10-010
OAAI
Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial
2024-05-010
PRE
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

伊维菌素用于社区成人新型冠状病毒肺炎 (原则): 一项开放、随机、对照、适应性的短期和长期结果平台试验

2024-04-015
OAAI
Long-Term Blood Pressure Control After Hypertensive Pregnancy Following Physician-Optimized Self-Management: The POP-HT Randomized Clinical Trial
2023-11-2832
OA
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
2022-03-2328
OAAI
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression
2021-11-223
OAAI
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
LANCET
IF88.5
2021-09-01157
OAAI
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III) : a randomised controlled trial
2021-06-01192
OA
Effectiveness and Cost-Effectiveness of a Self-Guided Internet Intervention for Social Anxiety Symptoms in a General Population Sample: Randomized Controlled Trial

在一般人群样本中,自我指导的互联网干预对社会焦虑症状的有效性和成本效益: 随机对照试验

2020-01-1023
OAAI
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

在HIV和HIV/HCV合并感染的人群中,医生对饮酒的评估是否有助于预测严重肝病的风险?

2019-10-155
OAAI
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study
2018-01-092
PREAI
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever
2016-05-2339
OAAI